Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EVDI safely and effectively. See full prescribing information for EVDI. EVDI (trabectedin) injection, for intravenous use Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
EVDI is indicated for the treatment of adult patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen [see Clinical Studies (14)].
- generic_name
- trabectedin
- product_names
- Trabectedin
- ndc
- 60505-6423, 60505-6423-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en